Cells for Cells

Search results

• Cells for Cells prepares to start commercial operations in Colombia in 2024 and advances plans in the U.S.

  Maroun Khoury

  22/09/23

  1 item of Media coverage

  Press/Media

• University of los Andes Researcher Has Provided New Data on Tissue Engineering (Understanding the Molecular Conformation and Viscoelasticity of Low Sol-Gel Transition Temperature Gelatin Methacryloyl Suspensions)

  Paulo César Díaz Calderón, Javier Ignacio Enrione, Juan Pablo Acevedo & Cristina Padilla

  10/05/23

  1 item of Media coverage

  Press/Media

• Studies in the Area of Medical Errors Reported from Universidad Abierta Interamericana (Patient Identification in the Prevention of Errors and Adverse Events: A Systematic Review)

  Fernando E. Figueroa

  6/04/23

  1 item of Media coverage

  Press/Media

• University of los Andes Researcher Publishes Findings in Pharmaceutics (Oral Administration as a Potential Alternative for the Delivery of Small Extracellular Vesicles)

  Francisca Alcayaga-Miranda & Maroun Khoury

  13/03/23

  1 item of Media coverage

  Press/Media

• U.S. Clinical Trial: Universidad de los Andes, Chile Listed a New Clinical Trial to Study "Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells (PANLAR-II)

  Fernando E. Figueroa

  2/03/23

  1 item of Media coverage

  Press/Media

• Findings from University of los Andes Advance Knowledge in Acute Respiratory Distress Syndrome (Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome)

  Francisca Alcayaga-Miranda, Maroun Khoury & Francisco Espinoza

  10/02/23

  1 item of Media coverage

  Press/Media

• US Patent Issued to UNIVERSIDAD DE LOS ANDES, CELLS FOR CELLS on Jan. 31 for "Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof" (Chilean Inventors)

  Juan Pablo Acevedo, Paulo César Díaz Calderón & Javier Ignacio Enrione

  1/02/23

  1 item of Media coverage

  Press/Media

• Patient Dosed With Mesenchymal Stem Cell-Derived Therapy for Osteoarthritis

  Maroun Khoury

  25/07/22

  1 item of Media coverage

  Press/Media

• Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis

  Maroun Khoury

  19/07/22

  1 item of Media coverage

  Press/Media

• CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis

  Maroun Khoury

  18/07/22 → 19/07/22

  19 items of Media coverage

  Press/Media

• CELLS for CELLS Treats the First-Ever Patient with an Exosome-Produced Therapy for Osteoarthritis

  Maroun Khoury

  19/07/22

  1 item of Media coverage

  Press/Media

• CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis

  Maroun Khoury

  18/07/22

  1 item of Media coverage

  Press/Media

• Cell for Cells starts cell therapy operations in the U.S. and closes agreement with the University of Miami

  Maroun Khoury

  18/02/22

  1 item of Media coverage

  Press/Media

• Revolutionary Chilean center will research the generation of new tissues and the use of cells to treat patients

  Maroun Khoury

  2/01/22

  1 item of Media coverage

  Press/Media

• The Campus Roundup: October 21, 2021

  Fernando E. Figueroa

  21/10/21

  1 item of Media coverage

  Press/Media

• Clinical Trial: Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1)

  Francisco Espinoza

  29/09/21

  2 items of Media coverage

  Press/Media

• US Patent Issued to Cells for Cells on June 22 for "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells" (Chilean Inventors)

  Maroun Khoury

  23/06/21

  1 item of Media coverage

  Press/Media

• VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize

  Juan Pablo Acevedo

  13/11/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Anti-angiogenic therapy based on exosomes derived from menstrual stem cells' Lapses

  Maroun Khoury

  16/10/20

  1 item of Media coverage

  Press/Media

• Australia Patent: Application for 'Treatment for infection composed of menstrual stem cells' Lapses

  Maroun Khoury

  15/10/20

  1 item of Media coverage

  Press/Media

• CELLS FOR CELLS S.A 's US Patent application for "METHOD FOR OBTAINING A COMPOSITION CONTAINING A SPECIFIC POPULATION OF UMBILICAL CORD MESENCHYMAL CELLS AND USES THEREOF" is in published phase now

  Maroun Khoury

  28/09/20

  1 item of Media coverage

  Press/Media

• Cells for Cells Applies for Patent on Method for Obtaining a Composition Containing a Specific Population of Umbilical Cord Mesenchymal Cells and Uses Thereof

  Maroun Khoury

  26/09/20

  1 item of Media coverage

  Press/Media

• Head Line: CELLS FOR CELLS S.A granted US Patent for "Device, platform, and assay for assessing cells"

  Juan Pablo Acevedo

  10/09/20

  1 item of Media coverage

  Press/Media

• US Patent Issued to CELLS FOR CELLS on Sept. 8 for "Device, platform, and assay for assessing cells" (Chilean Inventor)

  Juan Pablo Acevedo

  9/09/20

  1 item of Media coverage

  Press/Media

• Cells for Cells Obtains Patent for Device, Platform and Assay for Assessing Cells

  Juan Pablo Acevedo

  9/09/20

  1 item of Media coverage

  Press/Media